Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Cergutuzumab Biosimilar – Anti-CEACAM5, CEA, CD66e mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | engineered]1_kappa, IG-Gamma1 -[IL2 (interleukin 2, IL-2) 21-153 |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Cergutuzumab Biosimilar - Anti-CEACAM5, CEA, CD66e mAb - Research Grade |
|---|---|
| Source | CAS 1509916-03-3 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Cergutuzumab,CEA-IL-2v,RG7813,RO-6895882,CEACAM5, CEA, CD66e,anti-CEACAM5, CEA, CD66e |
| Reference | PX-TA1387 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IG-Gamma1 -[IL2 (interleukin 2, IL-2) 21-153, engineered]1_kappa |
| Clonality | Monoclonal Antibody |
Description of Cergutuzumab Biosimilar - Anti-CEACAM5, CEA, CD66e mAb - Research Grade
General information on Anti-CEACAM5/CEA/CD66e[Homo sapiens] (Cergutuzumab) Monoclonal Antibody
Cergutuzumab is investigated for the treatment of Advanced and/or Metastatic Solid Tumors.
Related products
Antigen
Human Carcinoembryonic antigen-related cell adhesion molecule 5(CEA) Recombinant Protein
PX-P3009 210€
Antigen
Human CD66b recombinant protein
PX-P5120 110€
Antigen
CD66a recombinant protein
PX-P5131 420€
ELISA
Cergutuzumab ELISA Kit
KPTX153 1179€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.